Evaluation of Clinical Symptoms and Serum Lead Level in Patients with History of Oral Opium Use being Admitted to Hazrat Rasoul Akram, Firoozgar, Firoozabadi and Haft Tir Hospitals, Tehran

Main Article Content

Majid Rezaei Tavirani
Hazhir Heidari Beigvand

Abstract

Introduction: Drug abuse and its complications is a socio-health problem in Middle Eastern countries such as Iran. Smugglers may add lead to drug during drug production, which is in order to increase its weight for greater benefit. Considering the frequency of the patients with various complaints among Iranians, this study was designed and conducted to evaluate the clinical symptoms and serum levels of lead in patients being admitted to Hazrat Rasoul Akram, Firoozgar, Firouzabadi and Haft Tir hospitals with any complaints.

Materials and Methods: In this case-control study, serum levels of lead were measured in 128 samples in case and control groups. The case group consisted of 64 patients using oral opium who being admitted to Rasoul Akram and Firoozgar, Haft Tir and Firouzabadi hospitals with different complaints in May 2017. The control group consisted of 64 patients with no history of addiction that were homogenized with the case group in terms of age and sex. They were evaluated for serum levels of lead and other variables. Data were analyzed by SPSS software.

Results: The mean serum lead level was 76.34±17.82 in the group using opium and was 7.68±3.72 in the control group that the difference was statistically significant (P <0.001). The most common complaints of patients were abdominal pain and symptoms of bowel obstruction. The mean rate of oral opium consumption was 1.73±0.23 in subjects under 50 years old and with a mean of 2.89±0.27 in subjects over 50 years old. Serum lead level was significantly (P = 0.032) increased compared to the amount consumed. Duration of oral opium consumption was 5 months to 30 years with a mean of 15.24 years, which was not significantly correlated to serum lead level (P = 0.213). Also, the hemoglobin range was significantly correlated to different levels of lead in patients consuming oral opium (P = 0.027).

Conclusion: The findings of the present study showed a high mean serum lead level in oral opium addicts in the study population. The results also confirm numerous reports suggesting the definitive diagnosis of lead poisoning as a justifying factor in addicted patients with nonspecific symptoms, which may indicate the need for serum lead level screening in opiate addicts to prevent more serious complications.

Keywords:
Serum lead level, oral opium use, clinical symptoms, drugs.

Article Details

How to Cite
Tavirani, M. R., & Beigvand, H. H. (2019). Evaluation of Clinical Symptoms and Serum Lead Level in Patients with History of Oral Opium Use being Admitted to Hazrat Rasoul Akram, Firoozgar, Firoozabadi and Haft Tir Hospitals, Tehran. Journal of Pharmaceutical Research International, 31(6), 1-8. https://doi.org/10.9734/jpri/2019/v31i630344
Section
Original Research Article

References

Engwa GA, Ferdinand PU, Nwalo FN, Marian N. Unachukwu mechanism and health effects of heavy metal toxicity in humans, in poisoning in the modern world-new tricks for an old dog? Intech Open; 2019.

Year F. Agency for toxic substances and disease registry; 2013.

Control CFD and Prevention. Adult blood lead epidemiology and surveillance-United States, 2008-2009. MMWR. Morbidity and Mortality Weekly Report. 2011;60(25):841.

Saper RB, Kales SN, Paquin J, Burns MJ, Eisenberg DM, Davis RB, Phillips RS. Heavy metal content of ayurvedic herbal medicine products. Jama. 2004;292(23): 2868-2873.

Mohamed M, Ugarte-Torres A, Groshaus H, Rioux K, Yarema M. Lead poisoning from a ceramic jug presenting as recurrent abdominal pain and jaundice. ACG Case Rep J. 2016;3(2):141–143.

Abdollahi MA, Sadeghi M, and Jalali N. Lead toxicity in employees of a paint factory. Medical Journal of The Islamic Republic of Iran (MJIRI). 1996;10(3):203-206.

Farzin L, Amiri M, Shams H, Ahmadi Faghih MA, Moassesi ME. Blood levels of lead, cadmium and mercury in residents of Tehran. Biological Trace Element Research. 2008;123(1-3):14-26.

Alinejad S, Zamani N, Abdollahi M, Mehrpour O. A narrative review of acute adult poisoning in Iran. Iranian Journal of Medical Sciences. 2017;42(4):327.

Abdollahi M, Ebrahimi Mehr M, Nikfar S, Jalali N. Monitoring of lead poisoning in simple workers of a copying center by flame atomic absorption spectroscopy. Medical Journal of the Islamic Republic of Iran (MJIRI). 1996;10(1):69-72.

Alegría M, K Álvarez, DiMarzio K. Immigration and mental health. Current Epidemiology Reports. 2017;4(2):145-155.

Latif Wani AB, Usmani JA. Lead toxicity: A review. Interdisciplinary Toxicology. 2015; 8(2):55.

Aghaee-Afshar M1, Khazaeli P, Behnam B, Rezazadehkermani M, Ashraf-Ganjooei N. Presence of lead in opium. Arch Iran Med. 2008;11(5):553-4.

Soltaninejad K, S Shadnia. Lead poisoning in opium abuser in Iran: A systematic review. International Journal of Preventive Medicine. 2018;9.

Masoodi M1, Zali MR, Ehsani-Ardakani MJ, Mohammad-Alizadeh AH, Aiassofi K, Aghazadeh R, Shavakhi A, Somi MH, Antikchi MH, Yazdani S. Abdominal pain due to lead-contaminated opium: A new source of inorganic lead poisoning in Iran. Arch Iran Med. 2006;9(1):72-5.

Algora M, Martín-Castillo A, Zabala P, Fernández MN. Lead poisoning due to drug addiction: A new source of poisoning with clinical interest and important epidemiological consequences. in Anales de Medicina Interna (Madrid, Spain: 1984); 1989.

Beattie AD, Briggs JD, Canavan JS, Doyle D, Mullin PJ, Watson AA. Acute lead poisoning: Five cases resulting from self-injection of lead and opium. QJM: An International Journal of Medicine. 1975; 44(2):275-284.

Antonini G, Palmieri G, Millefiorini E, Spagnoli LG, Millefiorini M. Lead poisoning during heroin addiction. The Italian Journal of Neurological Sciences. 1989;10(1):105-108.

Wolf C1, Binder R, Barth A, Konnaris C, Rüdiger HW. Chronic anemia and abdominal pain as a sequela of lead poisoning. Deutsche Medizinische Wochenschrift (1946). 2001;126(19):556-558.

Dequanter D, Lefebvre JC, Takieddine M, Belva P, Vaneukem P. An acute pseudo-cholecystitis. Rev Med Brux. 2001;22:439-41.

Anderson N, Gama R, Kapadia S. Herbal remedy poisoning presenting with acute abdomen and raised urine porphyrins. Annals of Clinical Biochemistry. 2001; 38(4):408-410.

Nemati A, Jafari S, Afshari M, Dahmardeh S, Tabrizian K. Comparing blood lead level among oral/inhaled opium addicts with a non-addict control group in the southeast of Iran. Addict Health. 2016; 8(4):235– 241.

Salehi H, Sayadi AR, Tashakori M, Yazdandoost R, Soltanpoor N, Sadeghi H, Aghaee-Afshar M. Comparison of serum lead level in oral drug male addicts with healthy group. Mashhad University of Medical Sciences Journal. 2009;52(3):129-132.

Lockitch G. Perspectives on lead toxicity. Clinical Biochemistry. 1993;26(5):371-381.

Weiss D, Tomasallo CD, Meiman JG, Alarcon W, Graber NM, Bisgard KM, Anderson HA. Elevated blood lead levels associated with retained bullet fragments—United States, 2003–2012. MMWR. Morbidity and Mortality Weekly Report. 2017;66(5):130.

Tandon SK, Chatterjee M, Bhargava A, Shukla V, Bihari V. Lead poisoning in Indian silver refiners. Science of the Total Environment. 2001;281(1-3):177-182.

Choy KD, Lee HS, Tan CH. Tan, Blood lead monitoring in a decorative ceramic tiles factory in Singapore. Singapore Medical Journal. 2004;45(4):176-179.

Shiri R, Ansari M, Ranta M, Falah-Hassani K. Lead poisoning and recurrent abdominal pain. Industrial Health. 2007;45(3):494-496.